Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Plasma levels of the soluble form of the FcγRIIa receptor vary with receptor polymorphisms and are elevated in rheumatoid arthritis.

Qiao J, Dunne E, Wines B, Kenny D, McCarthy GM, Hogarth PM, Xu K, Andrews RK, Gardiner EE.

Platelets. 2019 Aug 4:1-7. doi: 10.1080/09537104.2019.1647527. [Epub ahead of print]

PMID:
31378115
2.

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

Abadir E, Gasiorowski RE, Lai K, Kupresanin F, Romano A, Silveira PA, Lo TH, Fromm PD, Kennerson ML, Iland HJ, Ho PJ, Hogarth PM, Bradstock K, Hart DNJ, Clark GJ.

Mol Oncol. 2019 Jul 23. doi: 10.1002/1878-0261.12549. [Epub ahead of print]

3.

Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption.

Billings H, Wines BD, Dyer WB, Center RJ, Trist HM, Kent SJ, Hogarth PM.

AIDS Res Hum Retroviruses. 2019 Sep;35(9):842-852. doi: 10.1089/AID.2019.0047. Epub 2019 Aug 21.

4.

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease.

Anania JC, Chenoweth AM, Wines BD, Hogarth PM.

Front Immunol. 2019 Mar 19;10:464. doi: 10.3389/fimmu.2019.00464. eCollection 2019. Review.

5.

Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.

Yap ML, McFadyen JD, Wang X, Ziegler M, Chen YC, Willcox A, Nowell CJ, Scott AM, Sloan EK, Hogarth PM, Pietersz GA, Peter K.

Theranostics. 2019 Feb 7;9(4):1154-1169. doi: 10.7150/thno.29146. eCollection 2019.

6.

Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.

Parsons MS, Lee WS, Kristensen AB, Amarasena T, Khoury G, Wheatley AK, Reynaldi A, Wines BD, Hogarth PM, Davenport MP, Kent SJ.

J Clin Invest. 2019 Jan 2;129(1):182-191. doi: 10.1172/JCI122466. Epub 2018 Nov 26.

7.

Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.

Anand SP, Prévost J, Baril S, Richard J, Medjahed H, Chapleau JP, Tolbert WD, Kirk S, Smith AB 3rd, Wines BD, Kent SJ, Hogarth PM, Parsons MS, Pazgier M, Finzi A.

J Virol. 2019 Jan 17;93(3). pii: e01823-18. doi: 10.1128/JVI.01823-18. Print 2019 Feb 1.

8.

Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.

Wines BD, Tan CW, Duncan E, McRae S, Baker RI, Andrews RK, Esparon S, Gardiner EE, Hogarth PM.

J Thromb Haemost. 2018 Dec;16(12):2520-2525. doi: 10.1111/jth.14306. Epub 2018 Nov 20.

9.

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1.

Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM.

Front Immunol. 2018 Aug 20;9:1809. doi: 10.3389/fimmu.2018.01809. eCollection 2018.

10.

Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Vanderven HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, Jegaskanda S, Wheatley AK, Wentworth D, Wines BD, Hogarth PM, Rockman S, Kent SJ; INSIGHT FLU005 Pilot Study Writing Group.

J Infect Dis. 2018 Sep 22;218(9):1383-1393. doi: 10.1093/infdis/jiy328.

PMID:
29860297
11.

The cell surface phenotype of human dendritic cells.

Clark GJ, Silveira PA, Hogarth PM, Hart DNJ.

Semin Cell Dev Biol. 2019 Feb;86:3-14. doi: 10.1016/j.semcdb.2018.02.013. Epub 2018 Mar 27. Review.

PMID:
29499385
12.

Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.

Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ.

J Infect Dis. 2017 Dec 27;217(1):12-23. doi: 10.1093/infdis/jix554.

PMID:
29106590
13.

Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.

Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ.

Vaccine. 2017 Nov 7;35(47):6451-6458. doi: 10.1016/j.vaccine.2017.09.062. Epub 2017 Oct 10.

PMID:
29029940
14.

Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.

Yap ML, McFadyen JD, Wang X, Zia NA, Hohmann JD, Ziegler M, Yao Y, Pham A, Harris M, Donnelly PS, Hogarth PM, Pietersz GA, Lim B, Peter K.

Theranostics. 2017 Jun 25;7(10):2565-2574. doi: 10.7150/thno.19900. eCollection 2017.

15.

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.

Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, Kent SJ.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf1483. doi: 10.1126/scitranslmed.aaf1483.

PMID:
28794282
16.

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Madhavi V, Wines BD, Amin J, Emery S; ENCORE1 Study Group, Lopez E, Kelleher A; Sydney LTNP Study Group, Center RJ, Hogarth PM, Chung AW, Kent SJ, Stratov I.

J Virol. 2017 Aug 24;91(18). pii: e00700-17. doi: 10.1128/JVI.00700-17. Print 2017 Sep 15.

17.

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ.

JCI Insight. 2017 Jul 6;2(13). pii: 92750. doi: 10.1172/jci.insight.92750. eCollection 2017 Jul 6.

18.

Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.

McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW, Kent SJ.

J Immunol. 2017 Jul 15;199(2):816-826. doi: 10.4049/jimmunol.1602161. Epub 2017 Jun 14.

19.

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.

Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ.

Front Immunol. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595. eCollection 2017.

20.

Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.

Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, Gruell H, Parsons MS, Kent SJ.

J Virol. 2017 Jul 12;91(15). pii: e00603-17. doi: 10.1128/JVI.00603-17. Print 2017 Aug 1.

21.

Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.

Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ; ENCORE1 Study Group.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):345-353. doi: 10.1097/QAI.0000000000001380.

PMID:
28346319
22.

Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.

Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM.

Curr HIV Res. 2017;15(3):202-215. doi: 10.2174/1570162X15666170320112247. Review.

23.

Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.

Dyer WB, Tan JC, Day T, Kiers L, Kiernan MC, Yiannikas C, Reddel S, Ng K, Mondy P, Dennington PM, Dean MM, Trist HM, Dos Remedios C, Hogarth PM, Vucic S, Irving DO.

Brain Behav. 2016 Jul 14;6(10):e00516. eCollection 2016 Oct.

24.

Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells.

Wines BD, Yap ML, Powell MS, Tan PS, Ko KK, Orlowski E, Hogarth PM.

Immunol Cell Biol. 2017 Mar;95(3):272-279. doi: 10.1038/icb.2016.93. Epub 2016 Sep 20.

PMID:
27645493
25.

Targeting B cells in treatment of autoimmunity.

Franks SE, Getahun A, Hogarth PM, Cambier JC.

Curr Opin Immunol. 2016 Dec;43:39-45. doi: 10.1016/j.coi.2016.09.003. Epub 2016 Oct 5. Review.

26.

Clarifying the Confusion between Cytokine and Fc Receptor "Common Gamma Chain".

Brandsma AM, Hogarth PM, Nimmerjahn F, Leusen JH.

Immunity. 2016 Aug 16;45(2):225-6. doi: 10.1016/j.immuni.2016.07.006. No abstract available.

27.

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ.

EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28.

28.

Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.

Wines BD, Vanderven HA, Esparon SE, Kristensen AB, Kent SJ, Hogarth PM.

J Immunol. 2016 Aug 15;197(4):1507-16. doi: 10.4049/jimmunol.1502551. Epub 2016 Jul 6.

29.

Erratum to: CD14 hi CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.

Zhou J, Feng G, Beeson J, Hogarth PM, Rogerson SJ, Yan Y, Jaworowski A.

BMC Med. 2015 Nov 30;13:290. doi: 10.1186/s12916-015-0530-1. No abstract available.

30.

The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.

Chenoweth AM, Trist HM, Tan PS, Wines BD, Hogarth PM.

Immunol Rev. 2015 Nov;268(1):175-91. doi: 10.1111/imr.12366. Review.

PMID:
26497520
31.

Fc Receptors: Introduction.

Hogarth PM.

Immunol Rev. 2015 Nov;268(1):1-5. doi: 10.1111/imr.12372. No abstract available.

PMID:
26497509
32.

TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes.

Ramnath D, Tunny K, Hohenhaus DM, Pitts CM, Bergot AS, Hogarth PM, Hamilton JA, Kapetanovic R, Sturm RA, Scholz GM, Sweet MJ.

Immunol Cell Biol. 2015 Oct;93(9):771-9. doi: 10.1038/icb.2015.77. Epub 2015 Aug 25.

PMID:
26303210
33.

CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.

Zhou J, Feng G, Beeson J, Hogarth PM, Rogerson SJ, Yan Y, Jaworowski A.

BMC Med. 2015 Jul 7;13:154. doi: 10.1186/s12916-015-0391-7. Erratum in: BMC Med. 2015;13:290.

34.
35.

ZSWIM1: a novel biomarker in T helper cell differentiation.

Ko KK, Powell MS, Hogarth PM.

Immunol Lett. 2014 Aug;160(2):133-8. doi: 10.1016/j.imlet.2014.01.016. Epub 2014 Feb 4.

PMID:
24508175
36.

Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.

Trist HM, Tan PS, Wines BD, Ramsland PA, Orlowski E, Stubbs J, Gardiner EE, Pietersz GA, Kent SJ, Stratov I, Burton DR, Hogarth PM.

J Immunol. 2014 Jan 15;192(2):792-803. doi: 10.4049/jimmunol.1301554. Epub 2013 Dec 16.

37.

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Hogarth PM, Pietersz GA.

Nat Rev Drug Discov. 2012 Mar 30;11(4):311-31. doi: 10.1038/nrd2909. Review.

PMID:
22460124
38.

Isolation, expansion and characterisation of alloreactive human Th17 and Th1 cells.

Ko KK, Powell MS, Orlowski E, Prickett S, Krumbiegel D, Hogarth PM.

Immunol Lett. 2012 Mar 30;143(1):116-21. doi: 10.1016/j.imlet.2011.12.007. Epub 2012 Jan 8.

PMID:
22245119
39.

Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes.

Ramsland PA, Farrugia W, Bradford TM, Sardjono CT, Esparon S, Trist HM, Powell MS, Tan PS, Cendron AC, Wines BD, Scott AM, Hogarth PM.

J Immunol. 2011 Sep 15;187(6):3208-17. doi: 10.4049/jimmunol.1101467. Epub 2011 Aug 19.

40.

Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.

Wines BD, Ramsland PA, Trist HM, Gardam S, Brink R, Fraser JD, Hogarth PM.

J Biol Chem. 2011 Sep 23;286(38):33118-24. doi: 10.1074/jbc.M111.272252. Epub 2011 Jul 22.

41.

Functional expression of IgG-Fc receptors in human airway smooth muscle cells.

Xia YC, Schuliga M, Shepherd M, Powell M, Harris T, Langenbach SY, Tan PS, Gerthoffer WT, Hogarth PM, Stewart AG, Mackay GA.

Am J Respir Cell Mol Biol. 2011 May;44(5):665-72. doi: 10.1165/rcmb.2009-0371OC. Epub 2010 Jul 1.

42.

Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells.

Van de Velde NC, Mottram PL, Powell MS, Lim B, Holmdahl R, Hogarth PM.

Immunol Lett. 2010 May 4;130(1-2):82-8. doi: 10.1016/j.imlet.2009.12.005. Epub 2010 Jan 25.

PMID:
20005897
43.

IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB.

Cady CT, Powell MS, Harbeck RJ, Giclas PC, Murphy JR, Katial RK, Weber RW, Hogarth PM, Johnson S, Bonvini E, Koenig S, Cambier JC.

Immunol Lett. 2010 May 4;130(1-2):57-65. doi: 10.1016/j.imlet.2009.12.001. Epub 2009 Dec 30.

44.

Fc receptors.

Powell MS, Hogarth PM.

Adv Exp Med Biol. 2008;640:22-34. doi: 10.1007/978-0-387-09789-3_3. Review.

PMID:
19065781
45.

Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities.

Pietersz GA, Mottram PL, van de Velde NC, Sardjono CT, Esparon S, Ramsland PA, Moloney G, Baell JB, McCarthy TD, Matthews BR, Powell MS, Hogarth PM.

Immunol Cell Biol. 2009 Jan;87(1):3-12. doi: 10.1038/icb.2008.82. Epub 2008 Nov 25.

PMID:
19030019
46.

Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.

Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC.

Blood. 2008 Jan 1;111(1):165-74. Epub 2007 Sep 11.

47.

Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.

Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD.

Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15051-6. Epub 2007 Sep 11.

48.

An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.

Cendron AC, Wines BD, Brownlee RT, Ramsland PA, Pietersz GA, Hogarth PM.

Mol Immunol. 2008 Jan;45(2):307-19. Epub 2007 Jul 30.

PMID:
17673295
49.

FcgammaRII and multi-system autoimmune disease.

van de Velde NC, Mottram PL, Hogarth PM.

Springer Semin Immunopathol. 2006 Dec;28(4):329-38. Epub 2006 Nov 8. Review.

PMID:
17091247
50.

IgA receptors in health and disease.

Wines BD, Hogarth PM.

Tissue Antigens. 2006 Aug;68(2):103-14. Review.

PMID:
16866880

Supplemental Content

Loading ...
Support Center